A girl is more likely to die from an adverse reaction to Gardasil than from cervical cancer

In 2006 the Food and Drug Administration approved the drug Gardasil as a vaccine against certain types of human papillomavirus (HPV) which is the primary cause of cervical cancer in women.  Gardasil is manufactured by Merck and the company has aggressively marketed the drug  including political contributions through its PAC.

Many state and local governments have proposed that Gardasil be required for school girls as young as those entering the sixth grade.

Now one of the lead researchers for the Merck drug, Dr. Diane Harper,  says the "Pubic should receive more complete warnings."

"Parents and women must know that deaths occurred. Not all deaths that have been reported were represented in Dr. Slade's work, one-third of the death reports were unavailable to the CDC, leaving the parents of the deceased teenagers in despair that the CDC is ignoring the very rare but real occurrences that need not have happened if parents were given information stating that there are real, but small risks of death surrounding the administration of Gardasil."

After 26 million vaccinations, Dr. Harper says it will have NO effect on the rate of cervical cancer in the U.S.

To date, 15,037 girls have officially reported adverse side effects from Gardasil to the Vaccine Adverse Event Reporting System (VAERS). These adverse effects include Guilliane Barre, lupus, seizures, paralysis, blood clots, brain inflammation and many others. The CDC acknowledges that there have been 44 reported deaths."

Merck's Dr. Harper told CBS News that a girl is more likely to die from an adverse reaction to Gardasil than from cervical cancer.

What would be the point in promoting the inoculation of millions of girls and women with a useless, sometimes dangerous drug? And it really is useless: Merck's current project is to push it to pre-teen girls, but Dr. Harper pointed out that, once a girl hits puberty, any effectiveness of the vaccine disappears, and she has to start over again with the course of shots. And by the way, the efficacy of the drug in pre-teen girls hasn't actually been tested.

One thing we know about Gardasil is that each three-dose treatment costs $360, which has helped Merck a lot. It's been one of the company's top-selling drugs.